WallStreetZenWallStreetZen

NASDAQ: CLDX
Celldex Therapeutics Inc Stock Ownership - Who owns Celldex Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Celldex Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Richard M. WrightInsider2025-11-136,876$9.02
$62.00kBuy
Richard M. WrightInsider2025-11-1326,672$10.38
$276.86kBuy
Richard M. WrightInsider2025-11-1315,750$22.48
$354.06kBuy
Richard M. WrightInsider2025-11-1349,298$24.00
$1.18MSell
Freddy A. JimenezSVP GENERAL COUNSEL2025-08-13341$23.95
$8.17kSell
Freddy A. JimenezSVP GENERAL COUNSEL2025-08-13430$25.42
$10.93kSell

1 of 1

CLDX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLDX insiders and whales buy or sell their stock.

CLDX Shareholders

What type of owners hold Celldex Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Thomas S. Paluck11.49%7,632,346$224.77MInsider
Kynam Capital Management LP9.18%6,100,729$179.67MInstitution
Wellington Management Group LLP8.73%5,800,003$170.81MInstitution
Blackrock Inc8.29%5,505,988$162.15MInstitution
Fmr LLC7.47%4,962,088$146.13MInstitution
Vanguard Group Inc5.95%3,954,590$116.46MInstitution
Point72 Asset Management LP5.86%3,893,942$114.68MInstitution
Bellevue Group Ag5.35%3,557,669$104.77MInstitution
Commodore Capital LP4.56%3,028,335$89.18MInstitution
Medarex Inc4.46%2,960,848$87.20MInsider

1 of 3

CLDX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLDX84.76%15.24%Net SellingNet Buying
IMCR95.81%4.19%Net BuyingNet Buying
ZYME52.65%47.35%Net Buying
MAZE87.16%12.84%Net SellingNet Selling
DNTH58.17%41.83%Net BuyingNet Buying
View Top Biotech Stocks

Celldex Therapeutics Stock Ownership FAQ

Who owns Celldex Therapeutics?

Celldex Therapeutics (NASDAQ: CLDX) is owned by 106.44% institutional shareholders, 19.14% Celldex Therapeutics insiders, and 0.00% retail investors. Thomas S. Paluck is the largest individual Celldex Therapeutics shareholder, owning 7.63M shares representing 11.49% of the company. Thomas S. Paluck's Celldex Therapeutics shares are currently valued at $224.77M.

If you're new to stock investing, here's how to buy Celldex Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.